Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 50, Issue 4, 2006, Pages 348-354

  Zerva, C ^a   Koutsikos, J ^a   Palestidis, C ^a   Kounadi, E ^a   Gerali, S ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

131I ablative dose; 131I uptake; Differentiated thyroid carcinoma; Therapy; Thyroglobulin

Indexed keywords

AUTOANTIBODY; IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROXINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; DIAGNOSTIC VALUE; DOSE CALCULATION; FEMALE; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; PREDICTION; RADIATION DOSE; THERAPY EFFECT; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID GLAND; THYROIDECTOMY; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING; ADOLESCENT; CHILD; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 33846477290     PISSN: 11250135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
2. Schlumberger MJ, Pacini F. Initial treatment. In: Schlumberger MJ, Pacini F, editors. Thyroid tumors. 2nd ed. Paris: Nucleon; 2003. p.127-46.
3. Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nucl Med 1996;37: 1962-4.
4. Brierley J, Maxon HR. Radioiodine and external radiation therapy. In: Fagin JA, editor. Thyroid cancer. Boston/Dordrecht, London: Kluwer Academic Publishers; 1998.p.285-317.
5. Mazzaferri E, Kloos R. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
6. Demeure MJ, Clark OH. Surgery in the treatment of thyroid cancer. Endocrinol Metab Clin North Am 1990;19:663-83.
7. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
8. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-20.
9. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14:1063-75.
10. Tenenbaum F, Corone C, Schlumberger M, Parmentier C. Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. Eur J Cancer 1996;32A:1262.
11. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/ PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998;83:4116-22.
12. 131I therapy for elevated thyroglobulin levels. Thyroid 1997;7:273-6.
13. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998;83:4195-9.
14. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000;85:175-8.
15. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays. J Nucl Med 1988;29:1790-4.
16. 131I scintigraphy. Nucl Med Commun 2000;21:529-32.
17. Verkooijen RB, Stokkel MP, Smit JW, Pauwels EK. Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy. Eur J Nucl Med 2004;31:499-506.
18. Echenique RL, Kasi L, Haynie TP, Glenn HJ, Samaan NA, Stratton Hill C. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication. J Nucl Med 1982;23:235-40.
19. Szanto J, Vincze B, Sinkovics I, Karika Z, Daubner K, Peter I et al. Postoperative thyroglobulin level determination to follow-up patients with highly differentiated thyroid cancer. Oncology 1989;46:99-104.
20. Van Wyngaarden K, McDougall IR. Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue? Thyroid 1997;7:343-6.
21. Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of first serum thyroglobulin level after total thyroidectomy for early diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999;26:1448-52.